Spotlight on Communication experts: A Neuronet Blog with Cindy Birck
Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects on
AMYPAD
AMYPAD features prominently at AAIC2022
The 2022 Alzheimer’s Association International Conference (AAIC) took place from 31st July to 4th August
AMYPAD announces Last Patient Out in its Prognostic Study
On the 30 June, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD)
AMYPAD Post-Doc Merle Hoenig presents at SNMMI confrerence
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting is recognised as the
AMYPAD announces end of recruitment in the Prognostic and Natural History Study
On 11 May, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) project
AMYPAD hosts a disclosure biomarker symposium
On 1 April, the Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) project held an online
New partnership between AMYPAD and ADDI powers global open access to Alzheimer’s disease imaging data
A common sign of Alzheimer’s disease are deposits of a protein called beta amyloid. The
Neuronet convenes 8th meeting of its Scientific Coordination Board
On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
New partnership between AMYPAD and ADDI powers global open access to project’s data
The AMYPAD consortium is pleased to announce its collaboration with the Alzheimer’s Disease Data Initiative